HealthCor Management L.P. purchased a new stake in shares of Iqvia Holdings Inc (NYSE:IQV) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 783,380 shares of the medical research company’s stock, valued at approximately $76,693,000. Iqvia accounts for 2.5% of HealthCor Management L.P.’s portfolio, making the stock its 17th largest holding. HealthCor Management L.P. owned approximately 0.38% of Iqvia at the end of the most recent reporting period.
A number of other hedge funds have also recently bought and sold shares of the business. Winslow Evans & Crocker Inc. purchased a new stake in Iqvia during the fourth quarter valued at about $123,000. Focused Wealth Management Inc acquired a new position in shares of Iqvia during the fourth quarter worth about $166,000. Valeo Financial Advisors LLC acquired a new position in shares of Iqvia during the fourth quarter worth about $170,000. IFP Advisors Inc acquired a new position in shares of Iqvia during the fourth quarter worth about $200,000. Finally, Livforsakringsbolaget Skandia Omsesidigt acquired a new position in shares of Iqvia during the fourth quarter worth about $209,000. 92.34% of the stock is owned by hedge funds and other institutional investors.
Iqvia Holdings Inc (NYSE:IQV) opened at $105.60 on Monday. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 1.21. Iqvia Holdings Inc has a one year low of $76.80 and a one year high of $110.67. The company has a market capitalization of $21,993.32, a PE ratio of 22.91, a P/E/G ratio of 2.70 and a beta of 0.64.
A number of research analysts have commented on IQV shares. Evercore ISI started coverage on Iqvia in a research note on Thursday, January 18th. They set an “outperform” rating and a $112.00 price objective on the stock. Zacks Investment Research cut Iqvia from a “hold” rating to a “sell” rating in a research note on Tuesday, February 20th. Mitsubishi UFJ Financial Group started coverage on Iqvia in a research note on Friday, December 15th. They set a “neutral” rating and a $112.00 price objective on the stock. SunTrust Banks restated a “hold” rating and set a $110.00 price objective on shares of Iqvia in a research note on Monday, January 22nd. Finally, Piper Jaffray Companies restated a “hold” rating and set a $103.00 price objective on shares of Iqvia in a research note on Thursday, February 15th. One research analyst has rated the stock with a sell rating, six have given a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $110.02.
In related news, insider James H. Erlinger III sold 10,000 shares of the business’s stock in a transaction dated Wednesday, December 20th. The stock was sold at an average price of $101.21, for a total value of $1,012,100.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Michael J. Evanisko sold 816 shares of the business’s stock in a transaction dated Monday, March 5th. The shares were sold at an average price of $100.00, for a total value of $81,600.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 30,816 shares of company stock worth $3,093,400. Insiders own 6.00% of the company’s stock.
TRADEMARK VIOLATION WARNING: This report was first posted by American Banking News and is the property of of American Banking News. If you are reading this report on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The original version of this report can be read at https://www.americanbankingnews.com/2018/03/12/healthcor-management-l-p-invests-76-69-million-in-iqvia-holdings-inc-iqv-stock.html.
IQVIA Holdings Inc, formerly Quintiles IMS Holdings, Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.
Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.